ATGE Adtalem Global Education Inc. Common Shares
XNYS
97.55
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $86.97 – $154.91
- YTD
- -6.62%
- IV Rank (30D)
- 34.49
- Straddle Price
- $9.10
- P/C Vol Ratio
- 0.09
- Market Cap
- $3.4B
- Open
- $98.54
- Day Range
- $98.54 – $98.54
- Prev Close
- $98.54
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.00% |
| Beta vs SPY | 1.00 |
| Cost of Equity (CAPM) | 9.50% (VRP-adj) |
| WACC | 8.87% |
| Volatility Risk Premium | +64.1pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 22.7% |
| Rev. Growth (YoY, DCF input) | +8.0% |
| DCF Horizon | 12 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.08 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.4B |
| Return on Equity (TTM) | 18.4% |
| Book / Price | 37.3% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 57.4% |
| FCF Margin (TTM) | 19.5% |
| Debt / Equity | 0.37 |
| Quality Score | 5/6 — high quality (12y DCF) |
| Market-Implied Growth | -3.1% (reverse-DCF on current price) |
| SMA 50 | $105.51 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $97.88 |
| Bollinger Width / SMA20 | 8.4% (drives anchor stability) |
| Net Debt | $0.4B |
| Market Cap | $4B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $213.85 | 19% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $119.67 | 15% | median 16.3× · 7 peers |
| Peer EV/EBITDA | $112.79 | 15% | median 9.3× · 7 peers |
| Peer P/B | $111.15 | 3% | median 3.0× · 7 peers |
| Peer P/S | $132.33 | 10% | median 2.4× · 7 peers |
| Market Anchor (SMA50) | $105.51 | 39% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
- Industry (SIC)
- SERVICES-EDUCATIONAL SERVICES (8200) · industry map
- Exchange
- XNYS
- Market Cap
- $3.4B
- Employees
- 4,996
- List Date
- 1991-06-21
- CIK
- 0000730464
- Headquarters
- Chicago, IL
- Homepage
- https://www.adtalem.com
Adtalem Global Education Inc is an American for-profit educational company that operates various university and educational programs. The company has three segments namely Chamberlain; Walden; and Medical and Veterinary. It derives maximum revenue from Chamberlain segment.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
Executive Summary
Overall assessment: NEUTRAL with confidence level (6/10)
Key drivers: Strong technical momentum, positive news sentiment, and low volatility.
Primary risks:
- Potential for a pullback to the upper Bollinger Band ($101.92) or the SMA 50 ($105.51)
- Bearish MACD signal and negative beta
Investment thesis: Adtalem (ATGE) has shown strong technical momentum with recent positive news sentiment, but its low volatility may indicate limited upside potential in the near term.
Recent news sentiment impact: The positive news headlines have contributed to the stock's upward movement, but there is a risk of mean reversion if the market becomes more cautious.
Technical Analysis
Trend direction:
- Short-term (1-4 weeks): Uptrend
- Medium-term (1-3 months): Uptrend
- Long-term (3-12 months): Uptrend
Support/resistance levels:
- Upper Bollinger Band: $101.92
- Middle Bollinger Band: $97.88
- Lower Bollinger Band: $93.84
- SMA 50: $105.51
- SMA 200: $118.48
Momentum signals:
- RSI (14): 42.22 (neutral)
- MACD: -1.75 / Signal: 0.52 / Histogram: -2.26 (bearish)
Volume analysis:
- Volume SMA 20: 221018.05
- On-Balance Volume (OBV): 34643471.00
- Volume Rate of Change: -100.00% (indicating low volume)
News & Sentiment Analysis
Recent headlines summary:
- Positive news on Laureate Education, Adtalem's revenue outlook, and "Best Value Stock" recognition.
Sentiment assessment: Aggregate sentiment is POSITIVE, with 4 out of 5 recent headlines having a positive tone.
Catalyst identification: No significant catalysts are forthcoming in the near term, but earnings announcements could impact the stock's price.
Market narrative: The news sentiment aligns with the technical signals, indicating potential for further upward movement.
Risk & Volatility Assessment
Risk assessment:
- Beta: 0.42 (low risk relative to market)
- Volatility regime: Low volatility - stock moves less than market
- Options market signals:
- IV Rank: 94.1% (high - shows if volatility is historically high/low)
- Current IV: 217.6%
- Expected Move: $18.43 (13 DTE), 7-DTE: $18.43
Downside protection: Support levels: SMA 50 ($105.51) and the middle Bollinger Band ($97.88)
Market Context & Positioning
Sector performance: Adtalem is performing better than its sector in the short term.
Institutional activity: Institutional interest is moderate, with a volume rate of change indicating low buying pressure.
Correlation analysis: The stock moves less than market (R-squared interpretation), indicating a defensive posture.
Relative valuation: ATGE is positioned within its trading range, with limited upside potential in the near term.
Key Levels & Action Items
Critical price levels:
- Upper Bollinger Band: $101.92
- Middle Bollinger Band: $97.88
- Lower Bollinger Band: $93.84
- SMA 50: $105.51
- SMA 200: $118.48
Breakout/breakdown levels:
- Breakout above the upper Bollinger Band: potential for further upward movement
- Breakdown below the lower Bollinger Band: potential for downward momentum
Time-sensitive catalysts: Earnings announcements could impact the stock's price.
Risk management: Stop-loss levels: SMA 50 ($105.51) and the middle Bollinger Band ($97.88); position sizing considerations: 1-2% of portfolio.
Conclusion: Adtalem (ATGE) has shown strong technical momentum with recent positive news sentiment, but its low volatility may indicate limited upside potential in the near term. The stock's positioning within its trading range suggests a wait-and-see approach until market conditions change or earnings announcements are released.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-02-02 | After-Close | 5.32% | 3.09% | 0.58x | Within |
| 2021-04-29 | After-Close | 10.31% | 7.14% | 0.69x | Within |
| 2021-08-19 | After-Close | 7.08% | 3.87% | 0.55x | Within |
| 2021-11-03 | After-Close | 9.96% | 16.06% | 1.61x | Exceeded |
| 2022-02-08 | After-Close | 12.00% | 14.09% | 1.17x | Exceeded |
| 2022-08-11 | After-Close | 8.29% | 0.45% | 0.05x | Within |
| 2022-11-03 | After-Close | 13.26% | 0.98% | 0.07x | Within |
| 2023-05-02 | After-Close | 10.17% | 11.22% | 1.10x | Exceeded |
| 2023-08-10 | After-Close | 8.99% | 0.41% | 0.05x | Within |
| 2023-10-26 | After-Close | 12.51% | 15.83% | 1.27x | Exceeded |
| 2024-01-31 | After-Close | 8.14% | 7.45% | 0.92x | Within |
| 2024-05-02 | After-Close | 11.03% | 14.66% | 1.33x | Exceeded |
| 2024-08-06 | After-Close | 9.90% | 8.65% | 0.87x | Within |
| 2024-10-29 | After-Close | 10.40% | 9.51% | 0.91x | Within |
| 2025-01-30 | After-Close | 11.96% | 4.60% | 0.38x | Within |
| 2025-05-08 | After-Close | 9.75% | 17.58% | 1.80x | Exceeded |
| 2025-08-07 | After-Close | 10.23% | 2.19% | 0.21x | Within |
| 2025-10-30 | After-Close | 10.05% | 30.86% | 3.07x | Exceeded |
| 2026-01-28 | After-Close | 12.21% | 7.02% | 0.57x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
ATGE Options Activity & IV Rank
ATGE IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 2nd percentile of this name's own daily history, near the low end of its range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
ATGE Institutional Ownership (13F)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
ATGE Insider Trading (Form 4)
Latest: 2025-12-12| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2025-12-12 | Stephen W. Beard | Chairman & CEO | Gift (G) | −5,332 | — | EDGAR | |
| 2025-11-14 | Evan Trent | President, Adtalem Elevate | Mixed | +1,318 | $96.75 | $127.9K | EDGAR |
| 2025-11-14 | Sharon O'Keefe | Director | Award (A) | +1,445 | $96.86 | $140.0K | EDGAR |
| 2025-11-14 | Megan Noel | Chief Corp. Affairs Officer | Award (A) | +2,226 | $96.86 | $215.6K | EDGAR |
| 2025-11-14 | Georgette D. Kiser | Director | Mixed | +1,020 | $96.72 | $99.1K | EDGAR |
| 2025-11-14 | Sara Hill | CHRO | Award (A) | +1,673 | $96.86 | $162.0K | EDGAR |
| 2025-11-14 | Karen Sue Cox | President, Chamberlain Univ. | Mixed | +271 | $96.65 | $26.4K | EDGAR |
| 2025-11-14 | Michael W Malafronte | Director | Mixed | +919 | $96.70 | $89.3K | EDGAR |
| 2025-11-14 | Maurice Herrera | SVP - Chief Marketing Officer | Mixed | +1,407 | $96.76 | $136.5K | EDGAR |
| 2025-11-14 | William W Burke | Director | Mixed | +1,055 | $96.73 | $102.4K | EDGAR |
| 2025-11-14 | Michael Betz | Pres. Walden University & CDO | Mixed | +5,134 | $96.82 | $497.5K | EDGAR |
| 2025-11-14 | Kenneth J Phelan | Director | Mixed | +1,053 | $96.73 | $102.2K | EDGAR |
| 2025-11-14 | Donna J Hrinak | Director | Mixed | +1,101 | $96.74 | $106.8K | EDGAR |
| 2025-11-14 | Betty M. Vandenbosch | Director | Mixed | +1,024 | $96.72 | $99.4K | EDGAR |
| 2025-11-14 | Stephen W. Beard | Chairman & CEO | Tax (F) | −9,204 | $96.26 | -$886.0K | EDGAR |
ATGE Insider Holdings
23 insiders · @ $98.54| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Stephen W. Beard | Chairman & CEO | 445,198 | $43.87M | $32.8K | 35 | 2025-12-12 |
| 2 | Michael W Malafronte | Director | 101,890 | $10.04M | $2.94M | 14 | 2025-11-14 |
| 3 | Robert J. Phelan | Chief Financial Officer | 66,429 | $6.55M | $0 | 21 | 2025-11-14 |
| 4 | Douglas G. Beck | SVP, GC, Corp. Sec & ISS | 48,135 | $4.74M | $0 | 12 | 2025-11-14 |
| 5 | Lisa W Wardell | Director | 44,251 | $4.36M | -$76.17M | 46 | 2025-11-14 |
| 6 | Karen Sue Cox | President, Chamberlain Univ. | 33,596 | $3.31M | $0 | 15 | 2025-11-14 |
| 7 | Michael Betz | Pres. Walden University & CDO | 33,286 | $3.28M | -$380.0K | 9 | 2025-11-14 |
| 8 | Evan Trent | President, Adtalem Elevate | 24,134 | $2.38M | $0 | 6 | 2025-11-14 |
| 9 | Maurice Herrera | SVP - Chief Marketing Officer | 20,927 | $2.06M | -$931.2K | 13 | 2025-11-14 |
| 10 | Kenneth J Phelan | Director | 20,228 | $1.99M | $252.4K | 10 | 2025-11-14 |
ATGE Board & Officers
As of SEC filings through Oct 16, 2026Directors 11
- Michael W Malafronte · since Mar 30, 2016
- William W Burke · since Jan 12, 2017
- Georgette D. Kiser · since May 8, 2018
- Donna J Hrinak · since Oct 3, 2018
- Kenneth J Phelan · since Apr 29, 2020
- Sharon O'Keefe · since Apr 29, 2020
- William V Krehbiel · since Jun 6, 2022
- Lisa W Wardell · listed since Nov 2022
- Betty M. Vandenbosch · since Jan 8, 2024
- Emily C Chiu · since Aug 17, 2026
- Leslie Storms · since Aug 17, 2026
Officers 12
- Stephen W. Beard · Chairman & CEO · listed since Aug 2025
- Karen Sue Cox · President, Chamberlain Univ. · since Aug 27, 2018
- Scott Liles · President, Medical and Vet · since Apr 1, 2024
- Evan Trent · President, Adtalem Elevate · listed since Nov 2024
- Amelia Manning · President, Chamberlain Univ. · since May 18, 2026
- Robert J. Phelan · Chief Financial Officer · listed since Nov 2021
- Manjunath Gangadharan · VP, Chief Accounting Officer · since Apr 18, 2022
- Maurice Herrera · SVP - Chief Marketing Officer · listed since Aug 2023
- Megan Noel · Chief Corp. Affairs Officer · since May 12, 2025
- Douglas G. Beck · SVP, GC, Corp. Sec & ISS · listed since Aug 2023
- Sara Hill · CHRO · since Sep 9, 2024
- Michael Betz · Pres. Walden University & CDO · listed since Feb 2025
Changes in the last 10 years (76)
| Aug 17, 2026 | Leslie Storms became a director |
| Aug 17, 2026 | Emily C Chiu became a director |
| May 18, 2026 | Amelia Manning became President, Chamberlain Univ. |
| Aug 27, 2025 | Stephen W. Beard listed as Chairman & CEO (previously President and CEO) in SEC filings |
| May 12, 2025 | Megan Noel became Chief Corp. Affairs Officer |
| Feb 7, 2025 | Michael Betz listed as Pres. Walden University & CDO (previously President, Walden University) in SEC filings |
| Nov 15, 2024 | Evan Trent listed as President, Adtalem Elevate (previously SVP, Chief Strat. & Transform) in SEC filings |
| Nov 13, 2024 | Mayur Gupta reported in an SEC filing no longer being a director |
| Sep 9, 2024 | Sara Hill became CHRO |
| Aug 27, 2024 | Blake Simpson listed as SVP, Chief Comms & CA Officer (previously SVP, Chief Comms Officer) in SEC filings |
| Apr 10, 2024 | The company announced the departure of John W Md Danaher as Pres. - Adtalem Med & Vet in an SEC filing |
| Apr 1, 2024 | Scott Liles became President, Medical and Vet |
| Jan 8, 2024 | Betty M. Vandenbosch became a director |
| Nov 13, 2023 | Charles DeShazer reported in an SEC filing no longer being a director |
| Aug 29, 2023 | Douglas G. Beck listed as SVP, GC, Corp. Sec & ISS (previously SVP, GC & Corp. Secretary) in SEC filings |
| Aug 25, 2023 | Maurice Herrera listed as SVP - Chief Marketing Officer (previously Chief Marketing Officer) in SEC filings |
| Dec 5, 2022 | Blake Simpson became SVP, Chief Comms Officer |
| Nov 10, 2022 | Lyle Logan reported in an SEC filing no longer being a director |
| Nov 9, 2022 | Lisa W Wardell first listed as a director in an SEC filing |
| Aug 24, 2022 | Evan Trent became SVP, Chief Strat. & Transform |
| Jun 6, 2022 | William V Krehbiel became a director |
| May 17, 2022 | Michael Betz became President, Walden University |
| Apr 18, 2022 | Manjunath Gangadharan became VP, Chief Accounting Officer |
| Feb 28, 2022 | Cheryl James became SVP, CHRO |
| Feb 10, 2022 | Lisa W Wardell no longer listed as a director in SEC filings |
| Feb 10, 2022 | Lisa W Wardell no longer listed as Chairman, President and CEO in SEC filings |
| Nov 12, 2021 | Robert J. Phelan listed as Chief Financial Officer (previously Interim CFO) in SEC filings |
| Oct 18, 2021 | Maurice Herrera became Chief Marketing Officer |
| Sep 17, 2021 | James Raymond Bartholomew listed as SVP - Chamberlain University (previously President, DeVry University) in SEC filings |
| Sep 10, 2021 | Stephen W. Beard listed as President and CEO (previously Chief Operating Officer) in SEC filings |
| Sep 7, 2021 | Steven Tom became SVP Chief Customer Officer |
| Sep 7, 2021 | Paula R Singer became President Walden University |
| Sep 7, 2021 | John W Md Danaher became Pres. - Adtalem Med & Vet |
| Aug 24, 2021 | Holland Katherine Alice Boden listed as Group Pres, Adtalem Health (previously Gr Pres Medical and Healthcare) in SEC filings |
| Aug 10, 2021 | Mayur Gupta became a director |
| Jun 14, 2021 | Douglas G. Beck became SVP, GC & Corp. Secretary |
| May 14, 2021 | Robert J. Phelan listed as Interim CFO (previously VP, Chief Accounting Officer) in SEC filings |
| May 4, 2021 | James D White reported in an SEC filing no longer being a director |
| Apr 26, 2021 | Michael O Randolfi reported in an SEC filing no longer being SVP, Chief Financial Officer |
| Apr 2, 2021 | Charles DeShazer became a director |
| Aug 25, 2020 | Stephen W. Beard listed as Chief Operating Officer (previously COO and General Counsel) in SEC filings |
| Aug 25, 2020 | Donna Jennings listed as SVP, Human Resources (previously Senior Vice President, HR) in SEC filings |
| Apr 29, 2020 | Sharon O'Keefe became a director |
| Apr 29, 2020 | Kenneth J Phelan became a director |
| Feb 17, 2020 | Chaka M Patterson became SVP and General Counsel |
| Feb 11, 2020 | Robert J. Phelan became VP, Chief Accounting Officer |
| Nov 13, 2019 | Holland Katherine Alice Boden listed as Gr Pres Medical and Healthcare (previously SVP, Medical and Healthcare) in SEC filings |
| Aug 30, 2019 | Mehul R Patel listed as Group Pres, Financial Services (previously Group President, Prof. Ed.) in SEC filings |
| Aug 30, 2019 | Lisa W Wardell listed as Chairman, President and CEO (previously President and CEO) in SEC filings |
| Aug 30, 2019 | Fernando Lau listed as SVP, Chief Marketing Officer (previously Chief Marketing Officer) in SEC filings |
| Aug 26, 2019 | Patrick J Unzicker reported in an SEC filing no longer being Senior Vice President, Chief F |
| Aug 26, 2019 | Michael O Randolfi became SVP, Chief Financial Officer |
| May 9, 2019 | Thiago Aguiar Sayao became Group President, Business &Law |
| Feb 14, 2019 | Stephen W. Beard listed as COO and General Counsel (previously SVP and General Counsel) in SEC filings |
| Feb 13, 2019 | Donna Jennings listed as Senior Vice President, HR (previously Senior Vice President) in SEC filings |
| Oct 3, 2018 | Donna J Hrinak became a director |
| Sep 19, 2018 | Catherine C. Anderson became SVP, Strategy & Innovation |
| Aug 27, 2018 | Karen Sue Cox became President, Chamberlain Univ. |
| May 15, 2018 | Lisa M Sodeika listed as SVP, Corporate Affairs (previously SVP, External Relations and Re) in SEC filings |
| May 9, 2018 | Holland Katherine Alice Boden no longer listed as a director in SEC filings |
| May 9, 2018 | Holland Katherine Alice Boden first listed as SVP, Medical and Healthcare in an SEC filing |
| May 8, 2018 | Steven Altschuler became a director |
| May 8, 2018 | Georgette D. Kiser became a director |
| Feb 14, 2018 | Stephen W. Beard became SVP and General Counsel |
| Nov 7, 2017 | Mehul R Patel became Group President, Prof. Ed. |
| Nov 7, 2017 | James Raymond Bartholomew became President, DeVry University |
| Nov 7, 2017 | Carlos Filgueiras listed as Group President, Tech/Business (previously President, International) in SEC filings |
| Aug 28, 2017 | Eric P. Dirst listed as President, ATGE Shared Ops (previously President, DeVry Online) in SEC filings |
| May 23, 2017 | Gena L Ashe became SVP, CLO and Secretary |
| Feb 8, 2017 | Carlos Filgueiras listed as President, International (previously President, DeVry Brasil) in SEC filings |
| Jan 12, 2017 | William W Burke became a director |
| Jan 12, 2017 | Holland Katherine Alice Boden became a director |
| Dec 15, 2016 | International Value Advisers, LLC reported in an SEC filing no longer being a 10% owner |
| Dec 15, 2016 | Charles De Vaulx reported in an SEC filing no longer being a 10% owner |
| Dec 15, 2016 | Charles De Lardemelle reported in an SEC filing no longer being a 10% owner |
| Nov 10, 2016 | Fernando Lau became Chief Marketing Officer |
- Prev
- 1
Not reported recently (28)
- Blake Simpson · Last reported as SVP, Chief Comms & CA Officer in an SEC filing dated Dec 6, 2024
- Steven Tom · Last reported as SVP Chief Customer Officer in an SEC filing dated Nov 15, 2024
- Cheryl James · Last reported as SVP, CHRO in an SEC filing dated Feb 29, 2024
- James Raymond Bartholomew · Last reported as SVP - Chamberlain University in an SEC filing dated Aug 30, 2022
- Paula R Singer · Last reported as President Walden University in an SEC filing dated Sep 17, 2021
- Holland Katherine Alice Boden · Last reported as Group Pres, Adtalem Health in an SEC filing dated Aug 31, 2021
- Donna Jennings · Last reported as SVP, Human Resources in an SEC filing dated Aug 30, 2021
- Christopher C Nash · Last reported as SVP, Chief Information Officer in an SEC filing dated Aug 30, 2021
- Fernando Lau · Last reported as SVP, Chief Marketing Officer in an SEC filing dated Aug 30, 2021
- Chaka M Patterson · Last reported as SVP and General Counsel in an SEC filing dated Aug 31, 2020
- Thiago Aguiar Sayao · Last reported as Group President, Business &Law in an SEC filing dated Feb 28, 2020
- Mehul R Patel · Last reported as Group Pres, Financial Services in an SEC filing dated Nov 12, 2019
- Steven Altschuler · Last reported as a director in an SEC filing dated Nov 7, 2019
- Lisa M Sodeika · Last reported as SVP, Corporate Affairs in an SEC filing dated Aug 30, 2019
- Kathleen Carroll · Last reported as Vice President, Controller in an SEC filing dated Aug 30, 2019
- Catherine C. Anderson · Last reported as SVP, Strategy & Innovation in an SEC filing dated Aug 28, 2019
- Carlos Filgueiras · Last reported as Group President, Tech/Business in an SEC filing dated Feb 14, 2019
- Ann Hart · Last reported as a director in an SEC filing dated Nov 9, 2018
- Donna M Loraine · Last reported as President, Carrington Colleges in an SEC filing dated Nov 7, 2018
- Susan Groenwald · Last reported as President, Chamberlain in an SEC filing dated Feb 12, 2018
- John P Roselli · Last reported as President, Becker Professional in an SEC filing dated Sep 5, 2017
- Eric P. Dirst · Last reported as President, ATGE Shared Ops in an SEC filing dated Aug 31, 2017
- Robert A Paul · Last reported as President, DeVry University in an SEC filing dated Aug 28, 2017
- Gena L Ashe · Last reported as SVP, CLO and Secretary in an SEC filing dated Aug 24, 2017
- Fernando Ruiz · Last reported as a director in an SEC filing dated Nov 14, 2016
- Christopher B Begley · Last reported as a director in an SEC filing dated Nov 14, 2016
- David S Brown · Last reported as a director in an SEC filing dated Nov 7, 2016
- Alan G Merten · Last reported as a director in an SEC filing dated Nov 7, 2016
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2025-12-31 | $503.38M | $76.38M | $2.11 | $29.74M |
| Q1 '26 | 2025-09-30 | $462.29M | $61.83M | $1.67 | $130.55M |
| Q4 '25 | 2025-06-30 | $457.11M | $54.21M | $1.44 | $59.69M |
| Q3 '25 | 2025-03-31 | $466.06M | $60.83M | $1.59 | $207.91M |
| Q2 '25 | 2024-12-31 | $447.73M | $75.86M | $1.98 | $-19.02M |
| Q1 '25 | 2024-09-30 | $417.40M | $46.16M | $1.18 | $89.32M |
| Q4 '24 | 2024-06-30 | $409.91M | $49.42M | $1.25 | $60.27M |
| Q3 '24 | 2024-03-31 | $412.66M | $36.82M | $0.93 | $153.64M |
| Q2 '24 | 2023-12-31 | $393.24M | $39.89M | $0.98 | $-13.21M |
| Q1 '24 | 2023-09-30 | $368.85M | $10.65M | $0.25 | $95.07M |
| Q4 '23 | 2023-06-30 | $364.64M | $22.24M | $0.51 | $42.50M |
| Q3 '23 | 2023-03-31 | $369.08M | $45.87M | $1.00 | $108.00M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.